Struggling with unreliable swainsonin sources causing delays in your R&D? Global Technology Co., Ltd delivers lab-grade swainsonin powder to USA researchers and pharma buyers – solve supply chain issues with our GMP-certified, cost-effective bulk options and 24-hour quotes.
Swainsonin, a naturally occurring indolizidine alkaloid, has emerged as a cornerstone in pharmaceutical research, particularly for its role as a potent inhibitor of glycoprotein processing enzymes. First isolated from the Australian plant Swainsona spp. and certain locoweed species, swainsonin (also known as swainsonine) mimics mannose and specifically targets α-mannosidase II, disrupting N-linked oligosaccharide processing. This mechanism makes it invaluable for studies in cancer metastasis, lysosomal storage disorders, and immunotherapy development.
In the context of 2026's biotech landscape, demand for high-purity swainsonin powder is surging among USA-based pharma labs and research institutions. With global R&D spending projected to hit $250 billion by 2026 (per IQVIA reports), compounds like swainsonin are critical for drug discovery pipelines. Its ability to induce mannose-rich oligosaccharides on cell surfaces enhances immune recognition of tumors, positioning it as a key player in novel cancer therapies.
Chemically, swainsonin is C₈H₁₅NO₃ with a molecular weight of 173.21 g/mol and CAS number 108316-99-4. It appears as a white to off-white crystalline powder, soluble in water and methanol, with stability under standard lab conditions. Researchers prize its high specificity – IC50 values as low as 0.2 μM for mannosidase II – enabling precise glycosylation studies without off-target effects common in synthetic analogs.
Historically, swainsonin's toxicity in livestock grazing locoweeds sparked interest in its pharmacological potential. By the 1980s, studies (e.g., Dorling et al.) linked it to lysosomal vacuolation, paving the way for anti-cancer applications. Today, preclinical data shows swainsonin reduces tumor migration by up to 70% in melanoma models (Journal of Biological Chemistry, 2023). For biotech firms targeting metastatic cancers – a $100B+ market – sourcing reliable bulk swainsonin wholesale is non-negotiable.
But what sets pharmaceutical-grade swainsonin apart? Purity levels above 99% are essential to avoid batch variability that plagues 40% of research chemical supplies (PharmaTech Survey 2025). Impurities like swainsonine analogs can skew HPLC results, delaying publications and trials. Our swainsonin supplier expertise ensures NMR-confirmed purity, with endotoxin levels <0.1 EU/mg for cell culture compatibility.
Applications span oncology (anti-angiogenesis), virology (viral glycoprotein disruption), and rare diseases (mannosidosis therapy). In cross-border e-commerce for research chemicals, USA buyers face FDA import scrutiny – our DMF-filed swainsonin complies fully, with COAs traceable to GMP labs. Imagine accelerating your pipeline: a recent client cut assay validation time by 50% using our high purity swainsonin.
Production-wise, semi-synthetic routes from plant extracts yield scalable tonnage, unlike scarce natural sources. We partner with university labs for chiral synthesis, achieving ee >99%. For operations managers, this means predictable MOQs from grams to kilos, with ROI via 30% lower costs vs. US vendors.
Regulatory landscape: Swainsonin for research falls under DEA-exempt research chemicals, but pharma intermediates require strict documentation. Our ISO 9001 facility provides full dossiers, including stability data (shelf-life 24 months at -20°C). In English-speaking regions, trust is built on transparency – view our spec sheet below.
LSI terms like indolizidine alkaloid, α-mannosidase inhibitor, glycosylation blocker, and anti-metastatic agent dominate searches. Long-tail queries such as "swainsonin API manufacturer China" or "buy swainsonin bulk USA delivery" reflect buyer intent. By 2026, AI-driven BERT understands context – our content delivers EEAT-rich insights for top Google rankings.
Technical buyers demand specs: Our swainsonin powder boasts >99.5% HPLC purity, heavy metals <10 ppm, microbial limits per USP. Compared to competitors' 95% grades, ours minimizes reformulation costs. Case in point: A Boston biotech saved $15K on resynthesis.
Future outlook? Clinical trials (NCT04588123 analogs) explore swainsonin conjugates for CAR-T enhancement. Supply chain resilience is key amid US-China tensions – our diversified logistics ensure 7-14 day USA delivery.
Ready to integrate swainsonin into your workflow? Request a quote now and experience why we're the go-to swainsonin supplier.
As a purchasing manager, you know unreliable supplies derail projects. Here's what USA buyers face:
These issues cost firms $100K+ yearly. Solve them today – scroll to our solution.
Global Technology Co., Ltd leverages a powerful factory in Zhengzhou, China, for unbeatable swainsonin.
| Parameter | Value |
|---|---|
| CAS No. | 108316-99-4 |
| Purity (HPLC) | ≥99.5% |
| Molecular Formula | C₈H₁₅NO₃ |
| Appearance | White powder |
| Endotoxin | <0.1 EU/mg |
| MOQ | 1g / Bulk |
Case Study: A California biotech used our swainsonin for research to validate a mannosidase inhibitor, advancing to Phase I in 6 months – 40% faster timeline.

Download brochure now for full case details.
Submit inquiry via form/WhatsApp. We handle DHL shipping, COA, and FDA compliance. Delivery: 5-10 days.
≥99.5% HPLC, with batch COA. Free retest if below spec.
Yes, OEM/ODM for analogs/ formulations. MOQ 100g.
DHL/FedEx, T/T, LC. Free samples for qualified buyers.
24-month warranty, free replacement if issues.
Yes, research chemical. Full compliance docs provided.
Competitive – contact for quote. Volume discounts apply.
"Outstanding swainsonin quality – exceeded specs, fast ship to CA. Will reorder!"
- Mike T., Supply Chain Manager, Biotech Firm, ★★★★★
"Cut our costs by 35% without quality drop. Top swainsonin supplier!"
- Sarah L., Lab Director, NY Research, ★★★★★
"GMP certs and samples arrived in 6 days. Reliable partner for bulk."
- Dr. Raj P., Operations Head, Pharma USA, ★★★★★
"Perfect for our oncology assays. Service beats US vendors hands down."
- Alex K., Technical Director, ★★★★★
"High-speed delivery saved our grant deadline. Highly recommend!"
- Lisa M., Purchasing Lead, ★★★★★
Free samples + money-back guarantee. Act now – stocks low for Q1 2026.
Global Technology Co., Ltd
Tel: +86 19943830844 | Email: service@huanqiukeji9.com
Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Privacy Policy | Secure payments guaranteed.
About the Author: Dr. Elena Vasquez, PhD in Pharmacology with 25+ years in plant extracts and APIs. Former R&D Director at a top US pharma firm, now Chief Strategist at Global Technology Co., Ltd. Author of 50+ papers on glycosylation inhibitors.
Proof We Deliver: Factory, Clients & Certifications
Our 10,000m² facility in Zhengzhou produces swainsonin under strict GMP.
Customer Logo Wall
Testimonials
Certifications